Article info
Developmental defects
Original research
Biallelic cGMP-dependent type II protein kinase gene (PRKG2) variants cause a novel acromesomelic dysplasia
- Correspondence to Dr Karen E. Heath, INGEMM, Hospital Universitario La Paz, Madrid 28046, Spain; karen.heath{at}salud.madrid.org
Citation
Biallelic cGMP-dependent type II protein kinase gene (PRKG2) variants cause a novel acromesomelic dysplasia
Publication history
- Received May 18, 2020
- Revised September 22, 2020
- Accepted September 23, 2020
- First published October 26, 2020.
Online issue publication
December 15, 2021
Article Versions
- Previous version (26 October 2020).
- Previous version (23 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.